National Vaccine Injury Compensation Program; List of Petitions Received, 35783-35785 [2016-13073]
Download as PDF
<![CDATA[
mstockstill on DSK3G9T082PROD with NOTICES
Federal Register / Vol. 81, No. 107 / Friday, June 3, 2016 / Notices
MD 20993–0002, 301–796–9001, FAX:
301–847–8533, email: PCAC@
fda.hhs.gov, or FDA Advisory
Committee Information Line, 1–800–
741–8138 (301–443–0572 in the
Washington, DC area). A notice in the
Federal Register about last minute
modifications that impact a previously
announced advisory committee meeting
cannot always be published quickly
enough to provide timely notice.
Therefore, you should always check the
Agency’s Web site at https://
www.fda.gov/AdvisoryCommittees/
default.htm and scroll down to the
appropriate advisory committee meeting
link, or call the advisory committee
information line to learn about possible
modifications before coming to the
meeting.
Background: Section 503A of the
FD&C Act (21 U.S.C. 353a) describes the
conditions that must be satisfied for
human drug products compounded by a
licensed pharmacist or licensed
physician to be exempt from the
following three sections of the FD&C
Act: (1) Section 501(a)(2)(B) (21 U.S.C.
351(a)(2)(B)) (concerning current good
manufacturing practice (CGMP)); (2)
section 502(f)(1) (21 U.S.C. 352(f)(1))
(concerning the labeling of drugs with
adequate directions for use); and (3)
section 505 (21 U.S.C. 355) (concerning
the approval of human drug products
under new drug applications (NDAs) or
abbreviated new drug applications
(ANDAs)).
One of the conditions that must be
satisfied to qualify for the exemptions
under section 503A of the FD&C Act is
that a bulk drug substance (active
pharmaceutical ingredient) used in a
compounded drug product must meet
one of the following criteria: (1)
Complies with the standards of an
applicable United States Pharmacopoeia
(USP) or National Formulary
monograph, if a monograph exists, and
the USP chapter on pharmacy
compounding; (2) if an applicable
monograph does not exist, is a
component of a drug approved by the
Secretary of Health and Human Services
(the Secretary); or (3) if such a
monograph does not exist and the drug
substance is not a component of a drug
approved by the Secretary, appears on a
list (the ‘‘section 503A bulk drug
substances list’’) developed by the
Secretary through regulations issued by
the Secretary (see section
503A(b)(1)(A)(i) of the FD&C Act).
FDA will discuss with the committee
drugs proposed for inclusion on the
section 503A bulk drug substances list.
Agenda: The committee intends to
discuss six bulk drug substances
nominated for inclusion on the section
VerDate Sep<11>2014
21:20 Jun 02, 2016
Jkt 238001
503A bulk drug substances list. FDA
intends to discuss the following
nominated bulk drug substances:
Chrysin, cesium chloride, sodium
dichloroacetate, pyruvic acid, tea tree
oil, and 2,3-Dimercapto-1propanesulfonic acid (DMPS). The
nominators of these substances will be
invited to make a short presentation
supporting the nomination. During the
afternoon session, the committee will
receive updates on certain issues to
follow up on discussions from previous
meetings, including the option for
obtaining access to investigational new
drugs under expanded access.
FDA intends to make background
material available to the public no later
than 2 business days before the meeting.
If FDA is unable to post the background
material on its Web site prior to the
meeting, the background material will
be made publicly available at the
location of the advisory committee
meeting, and the background material
will be posted on FDA’s Web site after
the meeting. Background material is
available at https://www.fda.gov/
AdvisoryCommittees/Calendar/
default.htm. Scroll down to the
appropriate advisory committee meeting
link.
Procedure: Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
submissions may be made to the contact
person on or before June 15, 2016. Oral
presentations from the public will be
scheduled between approximately 9:30
a.m. and 9:40 a.m., 10:35 a.m. and 10:45
a.m., 11:40 a.m. and 11:50 a.m., 2:15
p.m. and 2:25 p.m., 3:20 p.m. and 3:30
p.m., and 4:40 p.m. and 4:50 p.m. Those
individuals interested in making formal
oral presentations should notify Cindy
Hong and submit a brief statement of the
general nature of the evidence or
arguments they wish to present, the
names and addresses of proposed
participants, and an indication of the
approximate time requested to make
their presentation on or before June 10,
2016. Time allotted for each
presentation may be limited. If the
number of registrants requesting to
speak is greater than can be reasonably
accommodated during the scheduled
open public hearing session, FDA may
conduct a lottery to determine the
speakers for the scheduled open public
hearing session. The contact person will
notify interested persons regarding their
request to speak by June 13, 2016.
Persons attending FDA’s advisory
committee meetings are advised that the
Agency is not responsible for providing
access to electrical outlets.
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
35783
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with disabilities.
If you require accommodations due to a
disability, please contact Cindy Hong at
least 7 days in advance of the meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our Web site at
https://www.fda.gov/
AdvisoryCommittees/
AboutAdvisoryCommittees/
ucm111462.htm for procedures on
public conduct during advisory
committee meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: May 31, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016–13169 Filed 6–2–16; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
National Vaccine Injury Compensation
Program; List of Petitions Received
Health Resources and Services
Administration, HHS.
ACTION: Notice.
AGENCY:
The Health Resources and
Services Administration (HRSA) is
publishing this notice of petitions
received under the National Vaccine
Injury Compensation Program (the
Program), as required by Section
2112(b)(2) of the Public Health Service
(PHS) Act, as amended. While the
Secretary of Health and Human Services
(HHS) is named as the respondent in all
proceedings brought by the filing of
petitions for compensation under the
Program, the United States Court of
Federal Claims is charged by statute
with responsibility for considering and
acting upon the petitions.
SUPPLEMENTARY INFORMATION: The
Program provides a system of no-fault
compensation for certain individuals
who have been injured by specified
childhood vaccines. Subtitle 2 of Title
XXI of the PHS Act, 42 U.S.C. 300aa–
10 et seq. provides that those seeking
compensation are to file a petition with
the U.S. Court of Federal Claims and to
serve a copy of the petition on the
Secretary of HHS, who is named as the
respondent in each proceeding. The
Secretary has delegated this
responsibility under the Program to
SUMMARY:
E:\FR\FM\03JNN1.SGM
03JNN1
mstockstill on DSK3G9T082PROD with NOTICES
35784
Federal Register / Vol. 81, No. 107 / Friday, June 3, 2016 / Notices
HRSA. The Court is directed by statute
to appoint special masters who take
evidence, conduct hearings as
appropriate, and make initial decisions
as to eligibility for, and amount of,
compensation.
A petition may be filed with respect
to injuries, disabilities, illnesses,
conditions, and deaths resulting from
vaccines described in the Vaccine Injury
Table (the Table) set forth at 42 CFR
100.3. This Table lists for each covered
childhood vaccine the conditions that
may lead to compensation and, for each
condition, the time period for
occurrence of the first symptom or
manifestation of onset or of significant
aggravation after vaccine
administration. Compensation may also
be awarded for conditions not listed in
the Table and for conditions that are
manifested outside the time periods
specified in the Table, but only if the
petitioner shows that the condition was
caused by one of the listed vaccines.
Section 2112(b)(2) of the PHS Act, 42
U.S.C. 300aa–12(b)(2), requires that
‘‘[w]ithin 30 days after the Secretary
receives service of any petition filed
under section 2111 the Secretary shall
publish notice of such petition in the
Federal Register.’’ Set forth below is a
list of petitions received by HRSA on
April 1, 2016, through April 30, 2016.
This list provides the name of
petitioner, city and state of vaccination
(if unknown then city and state of
person or attorney filing claim), and
case number. In cases where the Court
has redacted the name of a petitioner
and/or the case number, the list reflects
such redaction.
Section 2112(b)(2) also provides that
the special master ‘‘shall afford all
interested persons an opportunity to
submit relevant, written information’’
relating to the following:
1. The existence of evidence ‘‘that
there is not a preponderance of the
evidence that the illness, disability,
injury, condition, or death described in
the petition is due to factors unrelated
to the administration of the vaccine
described in the petition,’’ and
2. Any allegation in a petition that the
petitioner either:
a. ‘‘[S]ustained, or had significantly
aggravated, any illness, disability,
injury, or condition not set forth in the
Vaccine Injury Table but which was
caused by’’ one of the vaccines referred
to in the Table, or
b. ‘‘[S]ustained, or had significantly
aggravated, any illness, disability,
injury, or condition set forth in the
Vaccine Injury Table the first symptom
or manifestation of the onset or
significant aggravation of which did not
occur within the time period set forth in
VerDate Sep<11>2014
21:20 Jun 02, 2016
Jkt 238001
the Table but which was caused by a
vaccine’’ referred to in the Table.
In accordance with Section
2112(b)(2), all interested persons may
submit written information relevant to
the issues described above in the case of
the petitions listed below. Any person
choosing to do so should file an original
and three (3) copies of the information
with the Clerk of the U.S. Court of
Federal Claims at the address listed
above (under the heading FOR FURTHER
INFORMATION CONTACT), with a copy to
HRSA addressed to Director, Division of
Injury Compensation Programs,
Healthcare Systems Bureau, 5600
Fishers Lane, 08N146B, Rockville, MD
20857. The Court’s caption (Petitioner’s
Name v. Secretary of Health and Human
Services) and the docket number
assigned to the petition should be used
as the caption for the written
submission. Chapter 35 of title 44,
United States Code, related to
paperwork reduction, does not apply to
information required for purposes of
carrying out the Program.
FOR FURTHER INFORMATION CONTACT: For
information about requirements for
filing petitions, and the Program in
general, contact the Clerk, United States
Court of Federal Claims, 717 Madison
Place NW., Washington, DC 20005,
(202) 357–6400. For information on
HRSA’s role in the Program, contact the
Director, National Vaccine Injury
Compensation Program, 5600 Fishers
Lane, Room 08N146B, Rockville, MD
20857; (301) 443–6593, or visit our Web
site at: https://www.hrsa.gov/vaccine
compensation/.
Dated: May 26, 2016.
James Macrae,
Acting Administrator.
List of Petitions Filed
1. Christopher Stephen Fennell; Sun
City West, Arizona; Court of Federal
Claims No: 16–0413V
2. Willie Johnson; Dublin, Georgia;
Court of Federal Claims No: 16–
0415V
3. Maria Villanueva; Utuado, Puerto
Rico; Court of Federal Claims No:
16–0416V
4. Laura Friedel; Woodstock, Illinois;
Court of Federal Claims No: 16–
0417V
5. Kathleen Mosier; Akron, Ohio; Court
of Federal Claims No: 16–0418V
6. Christina Osenbach and Bryan
Osenbach on behalf of B. O.;
Boston, Massachusetts; Court of
Federal Claims No: 16–0419V
7. Meredith Pyers; Columbus, Ohio;
Court of Federal Claims No: 16–
0421V
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
8. Alexandria Skeens; Granville, Ohio;
Court of Federal Claims No: 16–
0423V
9. Marsha Crawford; Paris, Kentucky;
Court of Federal Claims No: 16–
0428V
10. Edward McMahon; Tucson, Arizona;
Court of Federal Claims No: 16–
0429V
11. Kristina Raab on behalf of J. R.; San
Diego, California; Court of Federal
Claims No: 16–0431V
12. Pella Parker; Los Angeles, California;
Court of Federal Claims No: 16–
0433V
13. Michele Jacob and Craig Jacob on
behalf of Ryan Jacob; New York,
New York; Court of Federal Claims
No: 16–0434V
14. Jason Guido on behalf of D. G.;
Rochester, Pennsylvania; Court of
Federal Claims No: 16–0435V
15. Carl L. Anderson; Baltimore,
Maryland; Court of Federal Claims
No: 16–0436V
16. Kelsi Amen; Grand Island, Nebraska;
Court of Federal Claims No: 16–
0437V
17. Martin Rausch; Avery, North
Carolina; Court of Federal Claims
No: 16–0438V
18. Timothy Koller; Neenah, Wisconsin;
Court of Federal Claims No: 16–
0439V
19. Christian Geideman and Erinn
Geideman on behalf of H. G. G.;
Menlo Park, California; Court of
Federal Claims No: 16–0443V
20. Vilma Espada Cubano; San Juan,
Puerto Rico; Court of Federal
Claims No: 16–0444V
21. Regina Murrell; Jackson,
Mississippi; Court of Federal
Claims No: 16–0445V
22. Kristen Bell; Alpharetta, Georgia;
Court of Federal Claims No: 16–
0450V
23. Lorraine Sofia; Lyndhurst, New
Jersey; Court of Federal Claims No:
16–0452V
24. Arlene Sandman; Boston,
Massachusetts; Court of Federal
Claims No: 16–0453V
25. Frederick Green; Newport, Rhode
Island; Court of Federal Claims No:
16–0454V
26. Linda Commesso; Boston,
Massachusetts; Court of Federal
Claims No: 16–0455V
27. Isaac Watson; Indianapolis, Indiana;
Court of Federal Claims No: 16–
0456V
28. Patricia Swanson; Beverly,
Massachusetts; Court of Federal
Claims No: 16–0457V
29. Betty D. Backman; Manhattan,
Kansas; Court of Federal Claims No:
16–0458V
30. Sandra E. Williams on behalf of
Richard Williams, Deceased;
E:\FR\FM\03JNN1.SGM
03JNN1
mstockstill on DSK3G9T082PROD with NOTICES
Federal Register / Vol. 81, No. 107 / Friday, June 3, 2016 / Notices
Surprise, Arizona; Court of Federal
Claims No: 16–0459V
31. Linda K. Russell; Tampa, Florida;
Court of Federal Claims No: 16–
0460V
32. Steven Patton; Vienna, Virginia;
Court of Federal Claims No: 16–
0461V
33. Scott Cipa; Vienna, Virginia; Court
of Federal Claims No: 16–0462V
34. Jessica Buckingham; New Castle,
Delaware; Court of Federal Claims
No: 16–0463V
35. Mette Rose and Soren Rose Kjaer on
behalf of F. R. K.; New York, New
York; Court of Federal Claims No:
16–0465V
36. Mette Rose and Soren Rose Kjaer on
behalf of M. R. K.; New York, New
York; Court of Federal Claims No:
16–0466V
37. Victoria Pusateri; Southgate,
Michigan; Court of Federal Claims
No: 16–0467V
38. Nathaniel Paul; Fairfax, Virginia;
Court of Federal Claims No: 16–
0468V
39. Rebecca S. Melgares; Milwaukee,
Wisconsin; Court of Federal Claims
No: 16–0470V
40. Arthur L. Trollinger; Graham, North
Carolina; Court of Federal Claims
No: 16–0473V
41. Tracy E. Carrozza; Princeton, New
Jersey; Court of Federal Claims No:
16–0474V
42. Allen O. Cabansag; Spring Valley,
California; Court of Federal Claims
No: 16–0475V
43. Luciana Desa; Washington, District
of Columbia; Court of Federal
Claims No: 16–0476V
44. Deborah Tebault on behalf of J. T.;
Phoenix, Arizona; Court of Federal
Claims No: 16–0478V
45. Stephen Vasas; Ann Arbor,
Michigan; Court of Federal Claims
No: 16–0479V
46. Theresa Hibbs; Shepherdsville,
Kentucky; Court of Federal Claims
No: 16–0481V
47. Stephanie Gilbert on behalf of P. L.;
Vienna, Virginia; Court of Federal
Claims No: 16–0484V
48. Sonya Tabor; Beverly Hills,
California; Court of Federal Claims
No: 16–0485V
49. The Estate of Frank Lee Kapp, Jr.,
Deceased; Salisbury, North
Carolina; Court of Federal Claims
No: 16–0487V
50. Leslie Lewis; Lexington, South
Carolina; Court of Federal Claims
No: 16–0488V
51. Christine Benshoff; Orwigsburg,
Pennsylvania; Court of Federal
Claims No: 16–0489V
52. Robert Hearn; Jackson, Mississippi;
Court of Federal Claims No: 16–
0493V
VerDate Sep<11>2014
21:20 Jun 02, 2016
Jkt 238001
53. John Neukom; Normangee, Texas;
Court of Federal Claims No: 16–
0495V
54. Heather Wright on behalf of B. W.;
Washington, District of Columbia;
Court of Federal Claims No: 16–
0498V
55. Julian Henley; Scottsbluff, Nebraska;
Court of Federal Claims No: 16–
0499V
56. Misty Pasco on behalf of M. P.;
Phoenix, Arizona; Court of Federal
Claims No: 16–0500V
57. Janis Pool; Lawrence, Kansas; Court
of Federal Claims No: 16–0503V
58. Jeffrey A. Bales; Greensboro, North
Carolina; Court of Federal Claims
No: 16–0505V
59. Terry Bartee; Antioch, California;
Court of Federal Claims No: 16–
0506V
60. Linda Barton; Lancaster,
Pennsylvania; Court of Federal
Claims No: 16–0508V
61. Richard George Laux; Farmington
Hills, Michigan; Court of Federal
Claims No: 16–0509V
62. Judith A. Pannick; Flint, Michigan;
Court of Federal Claims No: 16–
0510V
63. Laura Kerrin; Philadelphia,
Pennsylvania; Court of Federal
Claims No: 16–0511V
64. Rev. Andrew Thomas Moody on
behalf of E. G. M.; Houston, Texas;
Court of Federal Claims No: 16–
0513V
65. James Ritchie; Ponte Vedra Beach,
Florida; Court of Federal Claims No:
16–0514V
66. Thomas Smith; Weston, West
Virginia; Court of Federal Claims
No: 16–0520V
67. Shahid Mahroof; Stony Brook, New
York; Court of Federal Claims No:
16–0521V
68. Stephanie Smith; Allentown,
Pennsylvania; Court of Federal
Claims No: 16–0522V
69. Monika Piatek on behalf of N. P.;
Chicago, Illinois; Court of Federal
Claims No: 16–0524V
70. Patricia Rubio; Bedford, New
Hampshire; Court of Federal Claims
No: 16–0525V
71. Frederick Morrison; Gulf Breeze,
Florida; Court of Federal Claims No:
16–0526V
72. Gary Schilling; Boston,
Massachusetts; Court of Federal
Claims No: 16–0527V
73. Tiffany Harris on behalf of A. H.;
Boston, Massachusetts; Court of
Federal Claims No: 16–0528V
74. Lianna Roberts; Boston,
Massachusetts; Court of Federal
Claims No: 16–0529V
75. Jennifer Young; Canton, Michigan;
Court of Federal Claims No: 16–
0530V
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
35785
76. Scott Pudalov; Boulder, Colorado;
Court of Federal Claims No: 16–
0532V
77. Tracy Butler; Denver, Colorado;
Court of Federal Claims No: 16–
0534V
[FR Doc. 2016–13073 Filed 6–2–16; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
Findings of Research Misconduct
Office of the Secretary, HHS.
Notice.
AGENCY:
ACTION:
Notice is hereby given that
the Office of Research Integrity (ORI)
has taken final action in the following
case:
Karen M. D’Souza, Ph.D., University
of Chicago: Based on the report of an
investigation conducted by the
University of Chicago (UC) and
additional analysis conducted by ORI in
its oversight review, ORI found that Dr.
Karen M. D’Souza, former Research
Professional Associate, Department of
Surgery, UC, engaged in research
misconduct in research supported by
National Heart, Lung, and Blood
Institute (NHLBI), National Institutes of
Health (NIH), grants K08 HL081472 and
R01 HL107949.
ORI found that falsified and/or
fabricated data were included in the
following one (1) funded NIH grant, two
(2) publications, two (2) posters, and
one (1) presentation:
• R01 HL107949–01
• J Biol Chem. 285(18):13748–60, 2010
Apr 30 (hereafter referred to as ‘‘JBC
2010’’)
• J Biol Chem. 286(17):15507–16, 2011
Apr 29 (hereafter referred to as ‘‘JBC
2011’’)
• Gordon Conference 2006 poster:
‘‘Regulation of Myocardial bAdrenergic Receptor Signaling By
Protein Kinase C’’ (hereafter referred
to as ‘‘GC2006’’)
• Huggins 2010 poster: Gaq-mediated
activation of GRK2 by mechanical
stretch in cardiac myocytes; the role
of protein kinase C’’ (hereafter
referred to as ‘‘HP2010’’)
• Cardiac Research Day 2009
presentation: ‘‘Regulation of G
protein-coupled receptor signaling by
mechanical stretch in cardiac
myocytes’’ (hereafter referred to as
‘‘CR2009’’)
ORI found that Respondent reused
and falsely relabeled and/or falsely
spliced Western blot images, falsified
SUMMARY:
E:\FR\FM\03JNN1.SGM
03JNN1
]]>Agencies
[Federal Register Volume 81, Number 107 (Friday, June 3, 2016)]
[Notices]
[Pages 35783-35785]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-13073]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
National Vaccine Injury Compensation Program; List of Petitions
Received
AGENCY: Health Resources and Services Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Health Resources and Services Administration (HRSA) is
publishing this notice of petitions received under the National Vaccine
Injury Compensation Program (the Program), as required by Section
2112(b)(2) of the Public Health Service (PHS) Act, as amended. While
the Secretary of Health and Human Services (HHS) is named as the
respondent in all proceedings brought by the filing of petitions for
compensation under the Program, the United States Court of Federal
Claims is charged by statute with responsibility for considering and
acting upon the petitions.
SUPPLEMENTARY INFORMATION: The Program provides a system of no-fault
compensation for certain individuals who have been injured by specified
childhood vaccines. Subtitle 2 of Title XXI of the PHS Act, 42 U.S.C.
300aa-10 et seq. provides that those seeking compensation are to file a
petition with the U.S. Court of Federal Claims and to serve a copy of
the petition on the Secretary of HHS, who is named as the respondent in
each proceeding. The Secretary has delegated this responsibility under
the Program to
[[Page 35784]]
HRSA. The Court is directed by statute to appoint special masters who
take evidence, conduct hearings as appropriate, and make initial
decisions as to eligibility for, and amount of, compensation.
A petition may be filed with respect to injuries, disabilities,
illnesses, conditions, and deaths resulting from vaccines described in
the Vaccine Injury Table (the Table) set forth at 42 CFR 100.3. This
Table lists for each covered childhood vaccine the conditions that may
lead to compensation and, for each condition, the time period for
occurrence of the first symptom or manifestation of onset or of
significant aggravation after vaccine administration. Compensation may
also be awarded for conditions not listed in the Table and for
conditions that are manifested outside the time periods specified in
the Table, but only if the petitioner shows that the condition was
caused by one of the listed vaccines.
Section 2112(b)(2) of the PHS Act, 42 U.S.C. 300aa-12(b)(2),
requires that ``[w]ithin 30 days after the Secretary receives service
of any petition filed under section 2111 the Secretary shall publish
notice of such petition in the Federal Register.'' Set forth below is a
list of petitions received by HRSA on April 1, 2016, through April 30,
2016. This list provides the name of petitioner, city and state of
vaccination (if unknown then city and state of person or attorney
filing claim), and case number. In cases where the Court has redacted
the name of a petitioner and/or the case number, the list reflects such
redaction.
Section 2112(b)(2) also provides that the special master ``shall
afford all interested persons an opportunity to submit relevant,
written information'' relating to the following:
1. The existence of evidence ``that there is not a preponderance of
the evidence that the illness, disability, injury, condition, or death
described in the petition is due to factors unrelated to the
administration of the vaccine described in the petition,'' and
2. Any allegation in a petition that the petitioner either:
a. ``[S]ustained, or had significantly aggravated, any illness,
disability, injury, or condition not set forth in the Vaccine Injury
Table but which was caused by'' one of the vaccines referred to in the
Table, or
b. ``[S]ustained, or had significantly aggravated, any illness,
disability, injury, or condition set forth in the Vaccine Injury Table
the first symptom or manifestation of the onset or significant
aggravation of which did not occur within the time period set forth in
the Table but which was caused by a vaccine'' referred to in the Table.
In accordance with Section 2112(b)(2), all interested persons may
submit written information relevant to the issues described above in
the case of the petitions listed below. Any person choosing to do so
should file an original and three (3) copies of the information with
the Clerk of the U.S. Court of Federal Claims at the address listed
above (under the heading For Further Information Contact), with a copy
to HRSA addressed to Director, Division of Injury Compensation
Programs, Healthcare Systems Bureau, 5600 Fishers Lane, 08N146B,
Rockville, MD 20857. The Court's caption (Petitioner's Name v.
Secretary of Health and Human Services) and the docket number assigned
to the petition should be used as the caption for the written
submission. Chapter 35 of title 44, United States Code, related to
paperwork reduction, does not apply to information required for
purposes of carrying out the Program.
FOR FURTHER INFORMATION CONTACT: For information about requirements for
filing petitions, and the Program in general, contact the Clerk, United
States Court of Federal Claims, 717 Madison Place NW., Washington, DC
20005, (202) 357-6400. For information on HRSA's role in the Program,
contact the Director, National Vaccine Injury Compensation Program,
5600 Fishers Lane, Room 08N146B, Rockville, MD 20857; (301) 443-6593,
or visit our Web site at: https://www.hrsa.gov/vaccinecompensation/.
Dated: May 26, 2016.
James Macrae,
Acting Administrator.
List of Petitions Filed
1. Christopher Stephen Fennell; Sun City West, Arizona; Court of
Federal Claims No: 16-0413V
2. Willie Johnson; Dublin, Georgia; Court of Federal Claims No: 16-
0415V
3. Maria Villanueva; Utuado, Puerto Rico; Court of Federal Claims No:
16-0416V
4. Laura Friedel; Woodstock, Illinois; Court of Federal Claims No: 16-
0417V
5. Kathleen Mosier; Akron, Ohio; Court of Federal Claims No: 16-0418V
6. Christina Osenbach and Bryan Osenbach on behalf of B. O.; Boston,
Massachusetts; Court of Federal Claims No: 16-0419V
7. Meredith Pyers; Columbus, Ohio; Court of Federal Claims No: 16-0421V
8. Alexandria Skeens; Granville, Ohio; Court of Federal Claims No: 16-
0423V
9. Marsha Crawford; Paris, Kentucky; Court of Federal Claims No: 16-
0428V
10. Edward McMahon; Tucson, Arizona; Court of Federal Claims No: 16-
0429V
11. Kristina Raab on behalf of J. R.; San Diego, California; Court of
Federal Claims No: 16-0431V
12. Pella Parker; Los Angeles, California; Court of Federal Claims No:
16-0433V
13. Michele Jacob and Craig Jacob on behalf of Ryan Jacob; New York,
New York; Court of Federal Claims No: 16-0434V
14. Jason Guido on behalf of D. G.; Rochester, Pennsylvania; Court of
Federal Claims No: 16-0435V
15. Carl L. Anderson; Baltimore, Maryland; Court of Federal Claims No:
16-0436V
16. Kelsi Amen; Grand Island, Nebraska; Court of Federal Claims No: 16-
0437V
17. Martin Rausch; Avery, North Carolina; Court of Federal Claims No:
16-0438V
18. Timothy Koller; Neenah, Wisconsin; Court of Federal Claims No: 16-
0439V
19. Christian Geideman and Erinn Geideman on behalf of H. G. G.; Menlo
Park, California; Court of Federal Claims No: 16-0443V
20. Vilma Espada Cubano; San Juan, Puerto Rico; Court of Federal Claims
No: 16-0444V
21. Regina Murrell; Jackson, Mississippi; Court of Federal Claims No:
16-0445V
22. Kristen Bell; Alpharetta, Georgia; Court of Federal Claims No: 16-
0450V
23. Lorraine Sofia; Lyndhurst, New Jersey; Court of Federal Claims No:
16-0452V
24. Arlene Sandman; Boston, Massachusetts; Court of Federal Claims No:
16-0453V
25. Frederick Green; Newport, Rhode Island; Court of Federal Claims No:
16-0454V
26. Linda Commesso; Boston, Massachusetts; Court of Federal Claims No:
16-0455V
27. Isaac Watson; Indianapolis, Indiana; Court of Federal Claims No:
16-0456V
28. Patricia Swanson; Beverly, Massachusetts; Court of Federal Claims
No: 16-0457V
29. Betty D. Backman; Manhattan, Kansas; Court of Federal Claims No:
16-0458V
30. Sandra E. Williams on behalf of Richard Williams, Deceased;
[[Page 35785]]
Surprise, Arizona; Court of Federal Claims No: 16-0459V
31. Linda K. Russell; Tampa, Florida; Court of Federal Claims No: 16-
0460V
32. Steven Patton; Vienna, Virginia; Court of Federal Claims No: 16-
0461V
33. Scott Cipa; Vienna, Virginia; Court of Federal Claims No: 16-0462V
34. Jessica Buckingham; New Castle, Delaware; Court of Federal Claims
No: 16-0463V
35. Mette Rose and Soren Rose Kjaer on behalf of F. R. K.; New York,
New York; Court of Federal Claims No: 16-0465V
36. Mette Rose and Soren Rose Kjaer on behalf of M. R. K.; New York,
New York; Court of Federal Claims No: 16-0466V
37. Victoria Pusateri; Southgate, Michigan; Court of Federal Claims No:
16-0467V
38. Nathaniel Paul; Fairfax, Virginia; Court of Federal Claims No: 16-
0468V
39. Rebecca S. Melgares; Milwaukee, Wisconsin; Court of Federal Claims
No: 16-0470V
40. Arthur L. Trollinger; Graham, North Carolina; Court of Federal
Claims No: 16-0473V
41. Tracy E. Carrozza; Princeton, New Jersey; Court of Federal Claims
No: 16-0474V
42. Allen O. Cabansag; Spring Valley, California; Court of Federal
Claims No: 16-0475V
43. Luciana Desa; Washington, District of Columbia; Court of Federal
Claims No: 16-0476V
44. Deborah Tebault on behalf of J. T.; Phoenix, Arizona; Court of
Federal Claims No: 16-0478V
45. Stephen Vasas; Ann Arbor, Michigan; Court of Federal Claims No: 16-
0479V
46. Theresa Hibbs; Shepherdsville, Kentucky; Court of Federal Claims
No: 16-0481V
47. Stephanie Gilbert on behalf of P. L.; Vienna, Virginia; Court of
Federal Claims No: 16-0484V
48. Sonya Tabor; Beverly Hills, California; Court of Federal Claims No:
16-0485V
49. The Estate of Frank Lee Kapp, Jr., Deceased; Salisbury, North
Carolina; Court of Federal Claims No: 16-0487V
50. Leslie Lewis; Lexington, South Carolina; Court of Federal Claims
No: 16-0488V
51. Christine Benshoff; Orwigsburg, Pennsylvania; Court of Federal
Claims No: 16-0489V
52. Robert Hearn; Jackson, Mississippi; Court of Federal Claims No: 16-
0493V
53. John Neukom; Normangee, Texas; Court of Federal Claims No: 16-0495V
54. Heather Wright on behalf of B. W.; Washington, District of
Columbia; Court of Federal Claims No: 16-0498V
55. Julian Henley; Scottsbluff, Nebraska; Court of Federal Claims No:
16-0499V
56. Misty Pasco on behalf of M. P.; Phoenix, Arizona; Court of Federal
Claims No: 16-0500V
57. Janis Pool; Lawrence, Kansas; Court of Federal Claims No: 16-0503V
58. Jeffrey A. Bales; Greensboro, North Carolina; Court of Federal
Claims No: 16-0505V
59. Terry Bartee; Antioch, California; Court of Federal Claims No: 16-
0506V
60. Linda Barton; Lancaster, Pennsylvania; Court of Federal Claims No:
16-0508V
61. Richard George Laux; Farmington Hills, Michigan; Court of Federal
Claims No: 16-0509V
62. Judith A. Pannick; Flint, Michigan; Court of Federal Claims No: 16-
0510V
63. Laura Kerrin; Philadelphia, Pennsylvania; Court of Federal Claims
No: 16-0511V
64. Rev. Andrew Thomas Moody on behalf of E. G. M.; Houston, Texas;
Court of Federal Claims No: 16-0513V
65. James Ritchie; Ponte Vedra Beach, Florida; Court of Federal Claims
No: 16-0514V
66. Thomas Smith; Weston, West Virginia; Court of Federal Claims No:
16-0520V
67. Shahid Mahroof; Stony Brook, New York; Court of Federal Claims No:
16-0521V
68. Stephanie Smith; Allentown, Pennsylvania; Court of Federal Claims
No: 16-0522V
69. Monika Piatek on behalf of N. P.; Chicago, Illinois; Court of
Federal Claims No: 16-0524V
70. Patricia Rubio; Bedford, New Hampshire; Court of Federal Claims No:
16-0525V
71. Frederick Morrison; Gulf Breeze, Florida; Court of Federal Claims
No: 16-0526V
72. Gary Schilling; Boston, Massachusetts; Court of Federal Claims No:
16-0527V
73. Tiffany Harris on behalf of A. H.; Boston, Massachusetts; Court of
Federal Claims No: 16-0528V
74. Lianna Roberts; Boston, Massachusetts; Court of Federal Claims No:
16-0529V
75. Jennifer Young; Canton, Michigan; Court of Federal Claims No: 16-
0530V
76. Scott Pudalov; Boulder, Colorado; Court of Federal Claims No: 16-
0532V
77. Tracy Butler; Denver, Colorado; Court of Federal Claims No: 16-
0534V
[FR Doc. 2016-13073 Filed 6-2-16; 8:45 am]
BILLING CODE 4165-15-P
